Related Experiment Video
Updated: Jun 4, 2026
08:41
Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction
Published on: January 12, 2016
Elevated caspase 3 expression correlates with severe inflammation in Crohn's disease
Nafie Sedju1, Michael Naumann2, Michael Vieth3
1Institute of Pathology, Klinikum Bayreuth; Institute for University Teaching and Research Medical Campus Upper Franconia, Friedrich-Alexander-Universität Erlangen-Nürnberg, Bayreuth.
European Journal of Histochemistry : EJH
|June 3, 2026
Summary
Caspase 3 expression increases with severe inflammation in Crohn's disease patients. This finding in epithelial and immune cells may help differentiate between mild and severe inflammatory states.
Area of Science:
- Gastroenterology
- Immunology
- Cell Biology
Background:
- Apoptosis, or programmed cell death, is crucial for intestinal health.
- Dysregulation of apoptosis is linked to Crohn's disease pathogenesis.
- Limited data exist on caspase 3 expression in relation to Crohn's disease activity.
Purpose of the Study:
- To investigate caspase 3 expression in intestinal biopsies from Crohn's disease patients.
- To correlate caspase 3 levels with different disease activity states.
- To assess caspase 3 expression in both epithelial and immune cells.
Main Methods:
- Analysis of 289 paraffin-embedded intestinal biopsies.
- Inclusion of patients with active disease (mild/severe), upper GI involvement, remission, and non-inflamed controls.
- Immunohistochemistry and Remmele immunoreactive score (IRS) for caspase 3 assessment.
Main Results:
- Epithelial caspase 3 expression significantly increased in severe inflammation (p=0.012).
- Immune cell caspase 3 expression showed a more pronounced increase in severe inflammation (p<0.001).
- Expression patterns varied across disease activity states.
Conclusions:
- Caspase 3 expression is elevated in severe inflammatory states of Crohn's disease.
- Increased caspase 3 in epithelial and immune cells may serve as a biomarker.
- This could aid in distinguishing between mild and severe intestinal inflammation in Crohn's disease.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:24Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...